Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Virginia Health System, Box 800712, Charlottesville, VA 22908-0712, USA.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Virginia Health System, Box 800712, Charlottesville, VA 22908-0712, USA.
Obstet Gynecol Clin North Am. 2018 Mar;45(1):155-173. doi: 10.1016/j.ogc.2017.10.011.
Obstetrician gynecologists play a critical role in the identification of women who may carry a germline mutation placing them at an increased lifetime risk of gynecologic and nongynecologic cancers. Given this, all gynecologists must have a basic understanding of the most common hereditary cancer syndromes, the associated cancer risks, and possible risk-reducing interventions to play a proactive role in the care of these women. This article presents general guidelines and potential tools for identification of high-risk patients, reviews the current literature regarding genetic mutations associated with gynecologic malignancies, and proposes screening and risk-reduction options for high-risk patients.
妇产科医生在识别可能携带种系突变的女性方面发挥着关键作用,这些突变会使她们终生面临妇科和非妇科癌症的风险增加。考虑到这一点,所有的妇产科医生都必须对最常见的遗传性癌症综合征、相关的癌症风险以及可能的降低风险干预措施有基本的了解,以便在这些女性的护理中发挥积极作用。本文介绍了识别高危患者的一般指南和潜在工具,回顾了与妇科恶性肿瘤相关的遗传突变的现有文献,并为高危患者提出了筛查和降低风险的选择。